ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety) (NCT07559903)
🩺 Plain-English Summary (8th-Grade Level)
The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.
Who can join: Review the eligibility criteria below.
Location: Banner University Medical Center — Phoenix, Arizona
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (19 Sites)
- Banner University Medical Center — Phoenix, Arizona
- Holy Cross Health Fort Lauderdale — Fort Lauderdale, Florida
- Emory University Hospital Midtown — Atlanta, Georgia
- Emory University Hospital — Atlanta, Georgia
- Emory Saint Joseph's Hospital — Atlanta, Georgia
- Emory Johns Creek Hospital — Johns Creek, Georgia
- Tufts Medical Center — Boston, Massachusetts
- Brigham and Women's Hospital — Boston, Massachusetts
- Allina Health Minneapolis Heart Institute — Minneapolis, Minnesota
- The Mount Sinai Hospital — New York, New York
- New York-Presbyterian/Weill Cornell Medical Center — New York, New York
- Montefiore Medical Center — New York, New York
- St. Francis Hospital & Heart Center — Roslyn, New York
- Sanger Heart & Vascular Institute — Charlotte, North Carolina
- Duke University Hospital — Durham, North Carolina
- University Hospitals Cleveland Medical Center — Cleveland, Ohio
- Vanderbilt University Medical Center — Nashville, Tennessee
- Universitatsklinikum des Saarlandes — Homberg (Efze),
- University Clinical Centre of Serbia — Belgrade,
📞 Contact the Study Coordinator
Phone: (314) 761-3396
Email: daniel.alexander.gold@emory.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Coronary Artery Disease
- Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Extended — Stanford, California
- Genomic Investigation of Cardiovascular Diseases — La Jolla, California
- Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health — Boston, Massachusetts
- A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD — Mobile, Alabama
- Firehawk Rapamycin Target Eluting Coronary Stent North American Trial — Birmingham, Alabama
- Precision PCI Registry — Gainesville, Florida
Explore by condition: All Coronary Artery Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.